Very Low Density Lipoprotein Turnover in Young and Elderly Individuals

Intrahepatic and intramyocellular lipid concentrations are elevated in elderly individuals relative to young people, despite no significant difference in fasting plasma TAG concentrations. Our general hypothesis is that the increase in intrahepatic fat with age results from reduced VLDL turnover, and therefore elderly individuals in this study will display lower VLDL turnover rates than young individuals. The aims of this study are a) to compare VLDL turnover in young and elderly individuals, and b) to compare a bolus method and a constant infusion method of assessing VLDL turnover.

Study Overview

• Status: Terminated
• Conditions: Aging
• Intervention / Treatment: Procedure: Stable Isotope Infusion

Detailed Description

Several studies have shown an association between hypertriacylglycerolaemia and coronary artery disease. Additionally, ectopic fat distribution, in particular, deposition of excess lipid within the liver and skeletal muscle, has been shown to correlate negatively with insulin sensitivity, thus presenting a metabolic milieu in which risk of developing type 2 diabetes is elevated. Previous research from our group has shown that the triacylglycerol (TAG) concentration within the liver, and within skeletal muscle fibres IMCLs (intramyocellular lipids), is increased in elderly individuals compared with young people. The elevation of lipids in these particular tissues for the elderly group was observed despite no statistically significant difference in fasting plasma TAG concentration. As the plasma TAG concentration during the postabsorptive state is largely determined by the production and clearance rates of very low density lipoprotein triacylglycerol (VLDL-TAG), and increased liver fat content has been shown to drive production of large VLDL particles, it is important to gain an understanding of whether VLDL synthesis and breakdown differs between young and elderly individuals. Such new knowledge may offer an insight into why tissue lipids are elevated in the elderly. At present, no data exist in the literature describing VLDL turnover in elderly people. We hypothesise that very low density lipoprotein turnover will be reduced in elderly individuals compared with young people. The aims of this study are a) to determine whether fractional synthesis and breakdown rates of both the protein and lipid parts of the VLDL are different between young and elderly individuals, and b) to determine whether VLDL turnover values appear different when calculated using a constant infusion tracer method as compared with a bolus tracer method. Eight young men, eight young women, eight elderly men and eight elderly women will each participate in an 8-hour infusion study. Stable isotopes of glycerol, amino acids and fatty acids will be infused, and blood samples will be drawn in intervals during the study.

• Study Type: Observational
• Enrollment (Actual): 24

Contacts and Locations

Study Locations

• United States
  • Texas
    • Galveston, Texas, United States, 77550
      • University of Texas Medical Branch, Dept of Surgery

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 60 years to 75 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Healthy individuals from the Galveston area.

Description

Inclusion Criteria:

• Age 18 to 35 years, or 60 to 75 years.
• Body mass index ≤ 27 kg•m2
• Ability to sign informed consent.
• Score of ≥26 for Mini-Mental State Exam

Exclusion Criteria:

• Diabetics (plasma glucose concentration >200 mg/dl at 2 hr after oral intake of 75 g glucose).
• Fasting plasma triacylglycerol concentration above 500 mg/dl
• Kidney disease.
• Liver disease.
• Bleeding disorders.
• Anaemia (Hb < 13 g/dl in males or < 12 g/dl in females).
• Endocrine disease (with the exception of well-regulated hypothyroidism).
• Positive hepatitis or HIV screens.
• Alcohol (CAGE questionnaire; abnormal liver enzyme values) or drug abuse (amphetamines, cocaine, opioids, marijuana).
• Lipid altering agents.
• Score of <26 for Mini-Mental State Exam

Study Plan

How is the study designed?

Number of groups / cohorts

4

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Young Males; Males, age 18-35 years. 9-hour Stable isotope infusion	Procedure: Stable Isotope Infusion; 9-hour infusion of stable isotope tracers
Young Females; Females, age 18-35 years. 9-hour Stable isotope infusion	Procedure: Stable Isotope Infusion; 9-hour infusion of stable isotope tracers
Older Males; Males, age 60-75. 9-hour Stable isotope infusion	Procedure: Stable Isotope Infusion; 9-hour infusion of stable isotope tracers
Older Females; Females, age 60-75. 9-hour Stable isotope infusion	Procedure: Stable Isotope Infusion; 9-hour infusion of stable isotope tracers

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Very Low Density Lipoprotein (VLDL) Turnover	Turnover rates of VLDL-triglycerides and VLDL-ApoB (apolipoprotein B)-100, including synthesis and breakdown rates, measured during a 9-hour infusion trial.	9-hours

Collaborators and Investigators

• Sponsor: The University of Texas Medical Branch, Galveston
• Collaborators: National Institute on Aging (NIA)
• Investigators: Principal Investigator: Elisabet Borsheim, Ph.D., University of Texas

Study record dates

Study Major Dates

• Study Start: December 1, 2011
• Primary Completion (Actual): July 1, 2013
• Study Completion (Actual): July 1, 2013

Study Registration Dates

• First Submitted: April 10, 2014
• First Submitted That Met QC Criteria: April 10, 2014
• First Posted (Estimate): April 14, 2014

Study Record Updates

• Last Update Posted (Estimate): May 12, 2016
• Last Update Submitted That Met QC Criteria: May 10, 2016
• Last Verified: May 1, 2016

More Information

Terms related to this study

• Keywords: lipid metabolism; aging; very low density lipoproteins
• Other Study ID Numbers: 11-318; 1R01AG033761-01A1 (U.S. NIH Grant/Contract)